Diagnostics; Using both molecular and digital tools, Guardant Health is addressing challenges across the cancer care continuum. Its first product, the Guardant360 assay, came to market in 2014, and is now the most widely ordered comprehensive liquid biopsy commercially available ...

Animal, Reach, Testing, Atlas, Cell, Kth, Protein, 3D Culture, Ips, Machine Learning, Biopole, Eau, Energie, Sel, Hauts De France, Incubator, Top, Transfert, Data, Rennes, Surveillance, Course, Discovery, Drug, Big Data, Deep Learning, Cancer, Ia, Imagerie, Advances in Cell Based Screening, Astrazeneca, Congress, Hcs, Phenotypic Screening, Cambridge, Imagexpress, Molecular Devices, Human, Neurotoxicity, Sh Sy5Y, Chopin, Hypercholesterolemie, Medecine Personnalisee, Risques Cardiovasculaires, Beauty Products, Cosmetics, Virtual Reality ...

Immunoassay Systems; Cardiac Markers; Cancer Testing; Hematology; Subject Area; Diagnostic Testing; Molecular Diagnostics; Cardiac Testing; Point of Care Testing ...

MasSpec Pen was developed by the Livia S. Eberlin lab at the University of Texas at Austin as a new approach for cancer diagnosis. the device extracts biomolecules directly from tissue using a small volume of water. Using a mass spectrometer, we identify molecular profiles used to build unique statistical models to predict a cancer diagnosis. We seek strategic partnerships to apply the MasSpec Pen during surgery for ...